Bill would prevent drug makers from thwarting generic competition #pharmaceutical #manufacturing #companies

Posted On Aug 28 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #pharmaceutical #companies #india

Posted On Aug 9 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #marketing #pharmaceuticals

Posted On Aug 2 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #pharmaceutical #companies #list

Posted On Jul 10 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #par #pharma

Posted On Apr 11 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #d #pharma

Posted On Apr 3 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #zyg #pharma

Posted On Feb 13 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #pharmaceutical #industry #trends

Posted On Feb 1 2017 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #the #drug #company

Posted On Dec 14 2016 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …


Bill would prevent drug makers from thwarting generic competition #cardiome #pharma

Posted On Nov 23 2016 by

#generic drug companies # Lawmakers look to prevent drug makers from thwarting generic competition For the third time in less than two years, congressional lawmakers have introduced a bill designed to end a practice that generic drug makers say is used by brand-name rivals to thwart competition. Known as the Creating and Restoring Equal Access to Equivalent Samples Act, the bipartisan legislation comes amid ongoing complaints that brand-name drug makers sometimes refuse to provide samples to generic companies. They need samples to prove their copycat versions are equivalent to the brand-name drugs in order to pass regulatory muster. And the …